Markets:

Overview

News

Currencies

International

Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

33.98 +0.06 (+0.18%)

Official Closing Price Updated: 7:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Teva Pharmaceutical Industries Limited American Depositary Shares

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

22 23 Next >

New York Attorney General Says Teva Tried To Evade Accountability On Opioid Crisis: Report ↗

July 12, 2022

Reuters reported that New York's attorney general said Teva Pharmaceutical Industries Ltd (NY

Via Benzinga

Analyst Ratings for Teva Pharmaceutical Indus ↗

June 14, 2022

Within the last quarter, Teva Pharmaceutical Indus (NYSE:TEVA) has observed the following analyst ratings:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022 ↗

June 14, 2022

Upgrades

Via Benzinga

Why Generic Drugs Giant Teva Pharmaceutical Just Cut Its 2022 Outlook ↗

May 03, 2022

Foreign exchange rates are weighing heavily on sales, according to the firm's CEO.

Via Investor's Business Daily

FDA Rejects Teva - MedinCell's Schizophrenia Candidate ↗

April 20, 2022

Via Benzinga

Golden Cross Appears Before Teva Pharmaceutical Indus Investors ↗

May 27, 2022

If history is any guide, there may be good fortune ahead for shares of Teva Pharmaceutical Indus (NYSE:TEVA). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be...

Via Benzinga

Teva, Allergan Settle Opioid Lawsuit With West Virginia ↗

May 25, 2022

U.S. affiliate of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached an agreement with the Attorney General of West Virginia that settles the state's opioid-related claims.

Via Benzinga

Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients ↗

May 17, 2022

Via Benzinga

BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal ↗

May 17, 2022

Prospects of a global opioid deal getting done in 2022 suggest a “potential path to upside” for Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) stock, according to BofA Securities.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2022 ↗

May 17, 2022

Via Benzinga

4 Analysts Have This to Say About Teva Pharmaceutical Indus ↗

May 12, 2022

Over the past 3 months, 4 analysts have published their opinion on Teva Pharmaceutical Indus (NYSE:TEVA) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg ↗

May 11, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022 ↗

May 04, 2022

Upgrades

Via Benzinga

Teva Posts Mixed Q1 Earnings, Cuts FY22 Sales Guidance Citing Copaxone Competition, Yet Shares Rise ↗

May 03, 2022

Via Benzinga

The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs ↗

May 03, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Recap: Teva Pharmaceutical Q1 Earnings ↗

May 03, 2022

Teva Pharmaceutical Indus (NYSE:TEVA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More ↗

May 02, 2022

Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks...

Via Benzinga

Earnings Scheduled For May 3, 2022 ↗

May 03, 2022

Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.

Via Benzinga

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters ↗

April 25, 2022

Via Benzinga

JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters ↗

April 20, 2022

Via Benzinga

The Daily Biotech Pulse: Windtree Jumps On Istaroxime Data, Arcturus' COVID-19 Vaccine Trial Data, FDA Rejects Teva's Schizophrenia Med, Otonomy Aces Hearing Loss Study ↗

April 20, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

What Were Your Best And Worst Stock Buys? What Does The Zinger Nation Think? ↗

April 06, 2022

Admitting to success is a lot easier than failure and when it comes to stocks, not only is there money involved, but also questioning your — or your advisor's — judgment. And then there is the advice...

Via Benzinga

Good and Bad stock news ↗

April 05, 2022

Microsoft is down because of an FTC investigation of its possible anti-competitive moves.

Via Talk Markets

Futures Slide To Overnight Lows As Algos Spooked By EU Ban On Russian Coal ↗

April 05, 2022

After initially trading sharply higher around the European open, US stock futures dropped to session lows as traders digested the latest developments in the Ukraine war.

Via Talk Markets

West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters ↗

April 04, 2022

West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE:

Via Benzinga

CVS Health, Teva Settle Florida State's Opioid-Related Claims: Report ↗

March 30, 2022

Florida has reached more than $878 million in settlements with CVS Health Corp (NYSE: CVS) and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2022 ↗

April 05, 2022

Upgrades

Via Benzinga

Monday Markets News ↗

March 28, 2022

Japanese Takeda TAK shares failed to thrive after its edema prevention drug was approved.

Via Talk Markets

Friday Markets News ↗

March 25, 2022

Methane leaks in the Permian Basin are 6 times higher than estimates.

Via Talk Markets

Rhode Island Announces $107M Opioid Settlements With Teva, Allergan: Reuters ↗

March 22, 2022

Rhode Island's attorney general announced settlements worth $107 million against Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and AbbVie Inc's (NYSE: ABBV) Allergan unit to resolve claims over

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Teva Pharmaceutical Industries Limited American Depositary Shares (NY:TEVA)

Headline News about Teva Pharmaceutical Industries Limited American Depositary Shares

Starting at $3.75/week.

Subscribe Today